ASLAN Pharmaceuticals share#snapshot#suffix 136269059 / US04522R3093
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
ASLAN Pharmaceuticals Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2022 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2021 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2020 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2019 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2018 | ASLAN Pharmaceuticals Limited (spons. ADRs) | 0.00 | 0.00 | USD |
| 2017 | ASLAN Pharmaceuticals Limited (spons. ADRs) | - | - | USD |
| 2016 | ASLAN Pharmaceuticals Limited (spons. ADRs) | - | - | USD |
| 2015 | ASLAN Pharmaceuticals Limited (spons. ADRs) | - | - | USD |
| 2014 | ASLAN Pharmaceuticals Limited (spons. ADRs) | - | - | USD |
share#balance#profitpershare- ASLAN Pharmaceuticals
| -22 23 | -30.0 22 | -20.0 21 | -16.0 20 | -57.8 19 | -56.3 18 | -63.8 17 |
share#balance#salespershare- ASLAN Pharmaceuticals
| 5.8 23 | 0 22 | 0 21 | 0 20 | 3.7 19 | 0 18 | 0 17 |
share#balance#p_e_ratio- ASLAN Pharmaceuticals
ASLAN Pharmaceuticals Limited (spons. ADRs): share#balance#headline#theshare (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -22.00 | -29.96 | -20.03 | -16.03 | -57.78 | -56.31 | -63.83 |
| Gewinn je Aktie (unverwässert) | -21.51 | -29.43 | -19.26 | -16.88 | -57.79 | -56.30 | -63.83 |
| Gewinn je Aktie (verwässert) | -21.51 | -29.43 | -19.26 | -16.88 | -57.79 | -56.30 | -63.83 |
| Dividende je Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| share#balance#cell#dividend_payment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
ASLAN Pharmaceuticals Limited (spons. ADRs): share#balance#business_ratio (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 5.84 | 0.00 | 0.00 | 0.00 | 3.68 | 0.00 | 0.00 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | - | - |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | - | - |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| share#balance#cell#equity_ratio | -53.95 | 13.67 | 60.63 | -63.13 | -2.58 | 57.90 | 69.18 |
| share#balance#cell#debt_ratio | 153.95 | 86.33 | 39.37 | 163.13 | 102.58 | 42.10 | 30.82 |
ASLAN Pharmaceuticals Limited (spons. ADRs): share#balance#headline#income_statement (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 12.00 | 0.00 | 0.00 | 0.00 | 2.99 | 0.00 | 0.00 |
| share#balance#cell#sales_change | - | - | - | -100.00 | - | - | -100.00 |
| share#balance#cell#sales_gross_profit | 11.65 | -0.33 | -0.28 | -0.30 | 2.14 | -0.24 | -0.21 |
| share#balance#cell#sales_gross_profit_change | - | -17.25 | 5.25 | - | - | -15.53 | - |
| share#balance#cell#operating_income | -43.74 | -47.83 | -33.89 | -16.51 | -22.46 | -42.31 | -38.97 |
| share#balance#cell#operating_income_change | 8.55 | -41.11 | -105.26 | 26.50 | 46.91 | -8.57 | -347.22 |
| share#balance#cell#income_before_tax | -44.08 | -50.79 | -31.23 | -17.00 | -46.57 | -42.13 | -39.72 |
| share#balance#cell#income_before_tax_change | 13.21 | -62.64 | -83.68 | 63.49 | -10.52 | -6.08 | -338.22 |
| share#balance#cell#income_after_tax | -44.22 | -51.32 | -31.36 | -16.23 | -46.92 | -42.15 | -39.72 |
| share#balance#cell#income_after_tax_change | 13.84 | -63.64 | -93.29 | 65.42 | -11.33 | -6.11 | -338.22 |
ASLAN Pharmaceuticals Limited (spons. ADRs): share#balance#headline#balance (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 38 | 53 | 37 | 26 | 24 | 22 | 16 |
| Langzeit Gesamtverbindlichk. je Aktie | 1.41 | 17.01 | 17.70 | 14.86 | 19.54 | 17.72 | 15.07 |
| share#balance#cell#total_equity | -13 | 8 | 57 | -10 | -1 | 30 | 35 |
| share#balance#cell#total_equity_change | -258.84 | -85.40 | - | -523.68 | -105.50 | -13.97 | -15.20 |
| share#balance#cell#total_liabilities_and_equity | 25 | 61 | 95 | 16 | 23 | 53 | 51 |
| share#balance#cell#total_liabilities_and_equity_change | -59.75 | -35.26 | 487.72 | -31.07 | -55.63 | 2.79 | -5.13 |
ASLAN Pharmaceuticals Limited (spons. ADRs): share#balance#headline#other_data (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -21.51 | -29.43 | -19.26 | -16.88 | -57.79 | -56.30 | -63.83 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 26.93 | -52.82 | -14.09 | 70.79 | -2.65 | 11.81 | -306.85 |
| Gewinn je Aktie (verwässert) | -21.51 | -29.43 | -19.26 | -16.88 | -57.79 | -56.30 | -63.83 |
| Veränderung Gewinn je Aktie (verwässert) in % | 26.93 | -52.82 | -14.09 | 70.79 | -2.65 | 11.81 | -306.85 |
| share#balance#cell#employees | 35 | 34 | 27 | 18 | 23 | - | - |
| share#balance#cell#employees_change | 2.94 | 25.93 | 50.00 | -21.74 | - | - | - |
ASLAN Pharmaceuticals Limited (spons. ADRs) Termine
| Unternehmen | Event | Datum |
|---|
ASLAN Pharmaceuticals Limited (spons. ADRs) vergangene Termine
| Terminart | Info | Datum |
|---|
share#companyprofile#balance#staff#headline
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 0 | 0 | 23 | 18 | 27 |
| share#companyprofile#balance#staff#salesperemployee | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 50 | 29 | 22 | 16 | 94 |
| share#companyprofile#balance#staff#fixedassets | 1 | 24 | 1 | 1 | 1 |
| share#companyprofile#balance#staff#totalassets | 51 | 53 | 23 | 16 | 95 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 16 | 22 | 24 | 26 | 37 |
| share#companyprofile#balance#staff#totalequity | 35 | 30 | -1 | -10 | 57 |
| share#companyprofile#balance#staff#totalliabilities | 51 | 53 | 23 | 16 | 95 |